1. Home
  2. ENOV vs UE Comparison

ENOV vs UE Comparison

Compare ENOV & UE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ENOV
  • UE
  • Stock Information
  • Founded
  • ENOV 1995
  • UE 2014
  • Country
  • ENOV United States
  • UE United States
  • Employees
  • ENOV N/A
  • UE N/A
  • Industry
  • ENOV Fluid Controls
  • UE Real Estate
  • Sector
  • ENOV Industrials
  • UE Finance
  • Exchange
  • ENOV Nasdaq
  • UE Nasdaq
  • Market Cap
  • ENOV 2.1B
  • UE 2.2B
  • IPO Year
  • ENOV 2008
  • UE N/A
  • Fundamental
  • Price
  • ENOV $31.56
  • UE $17.64
  • Analyst Decision
  • ENOV Strong Buy
  • UE Hold
  • Analyst Count
  • ENOV 5
  • UE 1
  • Target Price
  • ENOV $58.00
  • UE $22.00
  • AVG Volume (30 Days)
  • ENOV 1.1M
  • UE 821.0K
  • Earning Date
  • ENOV 05-08-2025
  • UE 04-30-2025
  • Dividend Yield
  • ENOV N/A
  • UE 4.31%
  • EPS Growth
  • ENOV N/A
  • UE N/A
  • EPS
  • ENOV N/A
  • UE 0.63
  • Revenue
  • ENOV $2,150,191,000.00
  • UE $453,505,000.00
  • Revenue This Year
  • ENOV $8.13
  • UE $6.42
  • Revenue Next Year
  • ENOV $6.19
  • UE $4.60
  • P/E Ratio
  • ENOV N/A
  • UE $27.83
  • Revenue Growth
  • ENOV 18.32
  • UE 8.73
  • 52 Week Low
  • ENOV $29.32
  • UE $15.66
  • 52 Week High
  • ENOV $51.10
  • UE $23.85
  • Technical
  • Relative Strength Index (RSI)
  • ENOV 36.65
  • UE 39.87
  • Support Level
  • ENOV $30.65
  • UE $17.46
  • Resistance Level
  • ENOV $37.85
  • UE $19.00
  • Average True Range (ATR)
  • ENOV 1.31
  • UE 0.34
  • MACD
  • ENOV -0.32
  • UE -0.10
  • Stochastic Oscillator
  • ENOV 12.64
  • UE 9.78

About ENOV Enovis Corporation

Enovis Corp is a medical technology company that offers medical devices and services across the continuum of patient care, from injury prevention to joint replacement to rehabilitation after surgery, injury, or degenerative disease. Its reportable segments are Prevention & Recovery (P&R) and Reconstructive (Recon). The company generates the maximum revenue from the Prevention & Recovery segment, which includes products that are used to treat patients with musculoskeletal conditions resulting from degenerative diseases, deformities, traumatic events, and sports-related injuries. The Reconstructive segment provides a suite of reconstructive joint products for the hip, knee, shoulder, elbow, foot, ankle, and surgical productivity tools. Geographically, it derives key revenue from the U.S.

About UE Urban Edge Properties of Beneficial Interest

Urban Edge Properties is a real estate investment trust principally focused on the management and development of retail real estate properties in urban communities in the U.S. Having originally been created to hold the majority of Vornado Realty Trust's shopping center businesses, Urban Edge's asset portfolio is mostly composed of shopping centers and malls in terms of total square footage. The company's holdings include necessity and convenience-oriented retailers, such as department stores, grocers, health clubs, and restaurants. Urban Edge's properties are mainly located in the New York City metropolitan region and within the DC to Boston corridor. The company generates nearly all of its revenue through the collection of rent from a large number of tenants.

Share on Social Networks: